logo
High society, low ethics

High society, low ethics

You don't choose a medicine—your doctor does. And who chooses the doctor? Multibillion pharma companies. Till recently, doctors in India went on luxury junkets to exotic locations, were feted with lavish vacations and pricey gifts by pharma companies to promote their drugs. In August 2022, a PIL before the Supreme Court spotlighted alleged unethical pharma marketing around Dolo-650, a 650 mg paracetamol popular during Covid 19. It was reported that Micro Labs spent approximately `1,000 crore on 'freebies' to doctors—covering travel, gifts, and perks—to promote prescriptions of Dolo-650. The unethical practice of pampering the medical fraternity in exchange for writing prescriptions recommending specific medicines ran into a wall. The Centre implemented a Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 that prohibits pharmaceutical companies from offering freebies or any monetary benefits to the Hippocrates Oath takers. No more cumshaws, sponsored trips, or lavish hospitality from the pill makers for pill pushers.
But you can't keep a freeloader down. Unscrupulous doctors who missed the balmy holidays in exotic locations, the dinner parties and lavish gifts, all paid for by Big Pharma's came up with a devious solution to sidestep the UCPMP. Societies. In short, a few unprincipled medical practitioners would get together to form a medical society and hold seminars. These seminars are held on Big Pharma's tab; liberal payouts to support such 'informed' debates which could mean crores. It could be a Cardiologists' Society of Greater Kailash or an Orthopaedic Doctors' Association of Pune. The seminars would be held at a pricey location in a luxury hotel in India or abroad, and the doctors and invitees would pack their suitcases, probably take their families along and fly business class, of course, to discuss treatments on the beach.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

West Virginia ban on abortion medication upheld
West Virginia ban on abortion medication upheld

Time of India

time3 hours ago

  • Time of India

West Virginia ban on abortion medication upheld

A divided federal appeals court on Tuesday upheld West Virginia's near-total ban on abortion, including limits on the widely used medication abortion drug mifepristone. The 4th U.S. Circuit Court of Appeals in Richmond, Virginia, said the Food and Drug Administration's approval of mifepristone did not preempt West Virginia's law as applied to medication abortions, which account for more than half of U.S. abortions. Circuit Judge J. Harvie Wilkinson said a 2007 federal law giving the FDA more authority over "high-risk" drugs did not evince a clear intention to displace states' traditional right to protect their citizens' health and safety. Wilkinson also found no indication that Congress intended to guarantee nationwide access to mifepristone. "The debate joined by able and dedicated supporters and opponents of access to abortion medications is simply not one, in the absence of clear congressional direction, for this court to decide," the judge wrote. Tuesday's 2-1 decision is the first by a federal appeals court to say states can restrict use of the pill. In June 2024, the U.S. Supreme Court preserved access to mifepristone, rejecting an effort by anti-abortion doctors and groups to roll back FDA approval. West Virginia's law had been challenged by GenBioPro, a Nevada company that sells a generic version of mifepristone. Opponents said letting the law stand could allow other states to criminalize access to federally approved medications. The law "sets a dangerous precedent regarding access to other evidence-based health care that (the) FDA has deemed safe and effective," said Skye Perryman, president of the nonprofit Democracy Forward, which helped represent GenBioPro. Erin Hawley, a lawyer representing West Virginia, said the court "rightly refused GenBioPro's invitation to federalize the issue of abortion." Hawley is senior counsel at the nonprofit Alliance Defending Freedom, which also brought the Supreme Court mifepristone case. Governor Patrick Morrisey , a Republican who defended West Virginia's law as that state's attorney general, called the decision a "big win" that lets West Virginia "lead the nation in our efforts to protect life." DISREGARDING SUPREME COURT 'NOT AN OPTION' Mifepristone is the first pill, followed by the drug misoprostol, for medication abortion in the first 10 weeks of pregnancy, and won FDA approval in 2000. Twenty-eight states restrict access to medication abortions, according to the nonprofit Guttmacher Institute, which focuses on reproductive health. West Virginia's Unborn Child Protection Act banned abortion with narrow exceptions, including within the first 14 weeks of pregnancy for minors who are victims of rape and incest. Without opining on the law, Wilkinson said federal courts shouldn't substitute their policy preferences for those of state legislators. He also said voiding the law would amount to near "defiance" of Dobbs v. Jackson Women's Health Organization , the 2022 Supreme Court decision that eliminated the federal constitutional right to abortion. "Just after the Supreme Court restored the states' traditional authority to regulate abortion, GenBioPro would have us wrest it right back," Wilkinson wrote. "At a time when the rule of law is under blunt assault, disregarding the Supreme Court is not an option," he added. Wilkinson was appointed to the bench by Republican President Ronald Reagan. His opinion was joined by U.S. District Judge Rossie Alston, an appointee of Republican President Donald Trump who normally sits in Alexandria, Virginia. Circuit Judge DeAndrea Gist Benjamin, an appointee of Democratic President Joe Biden, dissented, saying West Virginia's law "erects barriers to life-saving healthcare for countless West Virginians in ways not envisioned by Congress." She also said the law could unduly burden patients in medically underserved areas elsewhere by forcing West Virginians to travel to other states for treatment. Tuesday's decision upheld an August 2023 ruling by U.S. District Judge Robert Chambers in Huntington, West Virginia.

The journey from pain to purpose of acid attack survivors
The journey from pain to purpose of acid attack survivors

The Hindu

time6 hours ago

  • The Hindu

The journey from pain to purpose of acid attack survivors

In 2009, Shaheen Malik, who was then 26 and also pursuing MBA, was attacked with acid outside her workplace. The reason: her colleagues felt threatened by her confidence and competence. It left Shaheen's face and vision permanently altered. 'I still remember the green colour of that liquid,' she says. 'For a second, I thought it was a prank. But the burning told me it was not.' She underwent 25 reconstructive surgeries. Even after a decade-and-a-half of the incident, her legal battle continues. Shaheen remembers how, in the beginning, hospitals refused to admit her because she could not pay up ₹5,00,000. 'What happened to me, happens to many. What does not happen is justice, support, or basic human care,' she says. The gap between trauma and treatment led Shaheen to set up Brave Souls on July 5, 2021. What started off as a Delhi-based NGO has grown into a pan-India movement offering medical and legal support to acid attack survivors. 'But more than that, a second chance at life for them,' she adds. Brave Souls, say the beneficiaries, is a sanctuary for survival, self-respect, and soaring dreams for women whose stories have unspeakable pain and unimaginable resilience. When Shaheen launched the organisation, she had nothing, no money. Only a vision that no survivor should feel helpless like shedid. Today, the organisation offers reconstructive surgeries, trauma counselling, legal assistance, literacy training, yoga, and vocational skills, all aimed at making the acid attack survivors financially independent. It works in cities across Haryana, Punjab, Chandigarh, Kolkata, and Delhi, and will soon open in Uttar Pradesh. From street plays to courtrooms and hospital ICUs to dance studios, the organisation has become a force behind the acid attack victims. Here, recovery of an affected person does not end with surgery. It begins when the survivor begins to live again. 'We organise dance sessions, music classes, and outings to public places,' says Shaheen because she believes, 'people must see them, and they must see people'. One initiative last Summer involved setting up a water and sharbat stall at Nizamuddin. People kept pouring in and many also stopped to ask who they were. 'This simple curiosity is the first step to awareness,' says Shaheen. She remembers a moving incident involving a family of seven who were all victims of an acid attack, which included a six-month-old and a 60-year-old. Initially turned away by private hospitals for lack of funds, the NGO fought to get them treatment under a Supreme Court ruling. Shaheen talks of Gulnas, a young woman who lost everything but not her spunk in the acid attack. 'Today, she works at an American firm and has received ₹38 lakh as the highest-ever compensation for gender-based violence. 'She showed me what true transformation looks like,' says Shaheen. Preeti who was set afire by her husband saw herself burning like Holi Dahan. A traumatised and suicidal Preeti was brought to the shelter by Shaheen. She has had four reconstructive surgeries and is learning to smile again. 'Sometimes the mirror still scares me. But I remind myself I did not do anything wrong. The one who harmed me should be ashamed, not me,' says Preeti. At 14, Rahat refused a boy's advances. In retaliation, he threw acid on her. The culprit was sentenced to eight years. Today, Rahat lives in the Brave Souls home, stitching clothes and holding on to her faith. 'I will continue to work hard and believe something good will come,' she says. When asked how she defines strength, Shaheen says, 'It is not taking revenge but showing up every day when hiding is easier and dreaming big when everyone tells you not to.'

Activists accuse food regulator of stalling on-pack labelling regulation
Activists accuse food regulator of stalling on-pack labelling regulation

Time of India

timea day ago

  • Time of India

Activists accuse food regulator of stalling on-pack labelling regulation

Representative image Public health advocates have accused the Food Safety and Standards Authority of India ( FSSAI ) of delaying tactics as it has sought three more months for its expert committee to finalise its report on front of pack nutritional labelling (FOPNL) regulation. The Supreme Court had in April directed that the exercise be completed in three months. This was after FSSAI failed to finalise the amendments two and a half years after the draft regulation was made public in September 2022 and comments were sought from all stakeholders and the public. Front of Pack labelling was proposed in 2014 by an expert committee constituted by FSSAI on the order of the Delhi High court. The order came on a public interest petition seeking labelling and a ban on sale of junk food in schools. Eleven years later, it is still hanging fire. Last week (July 7) FSSAI filed an application seeking extension of time to comply with the SC order passed on April 9. The application revealed that the FSSAI had organised stakeholder consultations with food business operators and other concerned stakeholders across four regions –Delhi Goa, Hyderabad and Kolkata— in May 2025. 'During the consultation sessions, stakeholders shared their views and comments on the draft regulations related to Front-Of-Pack Nutrition Labelling (FOPNL)' stated the application, adding that such meetings were 'essential feedback to the draft regulation' and needed to be placed before the expert committee. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Các chỉ số toàn cầu đang biến động — Đã đến lúc giao dịch! IC Markets Tìm hiểu thêm Undo Nutrition Advocacy in Public Interest (NAPi), a think tank on nutrition, has issued a statement questioning the meetings being organized by FSSAI with the industry when all stakeholders were given an equal opportunity to give their feedback when the draft was made public on September 13, 2022 and comments were invited. According to the FSSAI it received 14,000 comments and constituted an expert committee on February 17, 2023 to analyse the public feedback on the draft amendment notification. 'Why should the FSSAI begin a new process? Why these new invitees for comments could not give their comments when these were invited in September 2022?' asked NAPi in its statement adding that FSSAI had already ensured freedom from any regulation on FOPNL for almost three years for the food industry by delaying the finalising of the amendments. In response to RTI queries, the FSSAI has refused to make public the 14,000 comments it received from stakeholders and the public citing 'commercial confidence', indicating that the industry had already given its feedback. Its application seeking an extension stated that the draft report of the expert committee's recommendations was ready. NAPi questioned why the report was not being made public when it was ready even before the Supreme Court had ordered for the exercise to be completed in three months. FOPL, acknowledged globally as an effective policy measure to help consumers make healthier choices and reduce consumption of ultra-processed food, has been fought hard by the food industry worried about falling sales. However, with research repeatedly establishing that processed foods with high sugar, salt and fat and low fibre content are linked to rising incidence of non-communicable diseases such as diabetes, hypertension, heart ailments, and certain cancers, many countries have adopted FOPL. The FSSAI's extension application also indicates that even after the expert committee's report is submitted, it could take months before any regulation is finalized with several stages to be gone through.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store